SOLV - CIK 0001964738
Solventum Corp trades as SOLV and has a market capitalization of $14.02 B, making it the #762 largest US-listed company by market value. In its fiscal 2025 annual report the company posted revenue of $8.32B, up 0.9% from the prior year and net income of $1.56B. This page tracks Solventum Corp through 245 SEC filings, with financial statements and metrics updated as new reports are filed.
Net profit margin expanded from 16.5% to 18.7% over the same period - every figure below comes from the company's audited annual filings.
| Filing | Type | Filed |
|---|---|---|
| Major company event | 8-K | 2026-05-20 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
| Insider trade | 4 | 2026-05-18 |
Solventum Foundation and America's ToothFairy Launch National Effort to Expand Access to Preventive Dental Care
Solventum to Participate in the 2026 BofA Securities Health Care Conference
Solventum Reports First Quarter 2026 Financial Results :: Solventum Corporation (SOLV)
Get inspired by the stories behind our innovations and find medical resources including product regulatory information and instructions for use.
Solventum to Participate in the 2026 KeyBanc Healthcare Forum
The largest companies sharing Solventum Corp's SEC industry classification (surgical & medical instruments & apparatus).
Solventum Corp (SOLV) has a market capitalization of $14.02 B as of 2026-06-10, ranking #762 among US-listed companies.
Solventum Corp reported revenue of $8.32B for fiscal year 2025, an increase of 0.9% year over year.
Yes. Solventum Corp reported net income of $1.56B in its latest fiscal year.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
Dig into the full income statement, balance sheet, and cash flow statement with annual and quarterly views.